QTc interval prolongation associated with intravenous methadone.
about
QTc interval screening for cardiac risk in methadone treatment of opioid dependenceECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addictsA systematic review of the cardiotoxicity of methadoneMethadone treatment of chronic non-malignant pain and opioid dependence--a long-term follow-upSyncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.Drink, drugs, and the QT interval.QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients.The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.A modeling and simulation approach to characterize methadone QT prolongation using pooled data from five clinical trials in MMT patients.An analysis of the root causes for opioid-related overdose deaths in the United States.Toward a systematic approach to opioid rotation.Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit.Torsades de pointes associated with methadone and voriconazole.Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus.Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.Methadone induced torsades de pointes and ventricular fibrillation: A case review.Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trialMethadone for cancer pain: what have we learned from clinical studies?The successful use of parenteral methadone in a patient with a prolonged QTc interval.Case files of the Drexel University Medical Toxicology Fellowship: methadone-induced QTc prolongationThe Impact of Opioids on Cardiac Electrophysiology.Methadone death, dosage and torsade de pointes: risk-benefit policy implications.Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology.Intravenous Methadone for Severe Cancer Pain: A Presentation of 10 CasesMethadone-Associated QTc Prolongation: A Case Report and Review of the Literature.Interindividual variability of methadone response: impact of genetic polymorphism.Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitroConsensus guideline on parenteral methadone use in pain and palliative care.Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.Risk-factors for methadone-specific deaths in Scotland's methadone-prescription clients between 2009 and 2013A community-based evaluation of sudden death associated with therapeutic levels of methadone.Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?Methadone maintenance dosing guideline for opioid dependence, a literature review.Onsite QTc interval screening for patients in methadone maintenance treatment.Effect of methadone maintenance treatment on heroin craving, a literature review.Opioid side effects and their treatment in patients with chronic cancer and noncancer pain.QTc interval prolongation by d-propoxyphene: what about other analgesics?
P2860
Q24201880-39967D99-F549-420C-B7E9-2ECB3CF90975Q24235379-99D5CEF9-97FC-475A-BD11-47FEA975D3DFQ26766513-1132AD95-5DEB-4FE3-9EE4-052B173F4D09Q28257915-CC526260-3D9A-41A5-A5AA-58A94E320F21Q33154871-FD60D2D4-3CF2-47BC-A761-C54FA3FE5C49Q33158205-15004575-65A5-42CA-8B21-32D20CE36734Q33687681-0BD6BFBC-AB23-4F02-B5EA-AA58DD57B960Q33807411-68A2BEBA-1C58-46FA-B0E7-ED5769BA26EBQ33835424-E4534FC7-1823-4F55-83D5-3472878C5AA4Q33878154-8CE285AE-4A97-4807-95A5-21A6D52A45A7Q34129646-60B19A1F-5B13-4A68-8C73-6567DF4CE015Q34179339-A0BFD62D-EBF0-4E12-A079-AC25F8B75C95Q34192078-4964D21C-7DE3-41AC-845B-DB74A07213C4Q34394425-601463AA-F46D-49C5-8867-3982BAC67A5EQ34419506-1A870560-3173-4A94-B1EE-364A69ADC426Q34527805-5A27C8CB-9BCF-4786-86F9-BFE2863C2D7BQ34606790-12A89959-E551-485C-9035-502E2511C87CQ35094562-0AEF4E37-A9ED-41B4-8187-B45EF18650A8Q35160624-6696AE2A-392A-4061-904F-390AFC624A86Q35959993-57A8EA1A-DCEC-4E3E-81D4-6F62C73A8280Q36135137-04C1F23B-B21C-46C7-AD08-3F5A942CD4DEQ36202929-C1EAD618-649E-4DB3-B3D1-C7D42205933EQ36548333-F1A8FECD-9435-48F1-AA7B-254106145A44Q36728665-72C52C04-273D-4FB3-95BD-8A2142416F67Q36764780-ADD8FB51-76A5-49E4-A378-35D0647B353BQ36811537-A959AAA0-1FB6-4DA4-AE3A-12751258472EQ36969714-3DAAA21A-8977-4FDD-A69F-6287D3ACDB76Q37101714-5D4D1AC2-8A0E-4340-80A5-FCFB3B58C1ADQ37142009-113B4E5F-85FA-4446-A0B1-5EB389763E99Q37161503-746FF81E-BCB9-4068-93A6-0F8D82F3B703Q37172055-36B81240-7C73-4861-9F65-F8965EA17E09Q37248049-0F613E7F-C70D-4FD3-9422-D667B8FA28E8Q37304594-DF7E82F0-F27F-403E-957F-EFB618CD495BQ37326899-BDCF45D4-A2CE-4090-9A65-5CFCDF22EBC2Q37636417-80A84CE9-0BE8-4C6D-A5FF-0FF5932ECF32Q37730680-8F1468A2-0BE8-4334-8FC5-A2ED30CD2FFAQ37730683-2369C724-01F8-49F5-A0E4-9666A131E482Q37827079-96D6413F-B587-4547-8130-6B85F06E859FQ37933355-65A6AC7E-7434-4EB5-9BE1-C8C3DDD3CEBFQ38008460-CF48FF9B-8E30-4B04-97B2-09E67765FAEB
P2860
QTc interval prolongation associated with intravenous methadone.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
QTc interval prolongation associated with intravenous methadone.
@ast
QTc interval prolongation associated with intravenous methadone.
@en
QTc interval prolongation associated with intravenous methadone.
@nl
type
label
QTc interval prolongation associated with intravenous methadone.
@ast
QTc interval prolongation associated with intravenous methadone.
@en
QTc interval prolongation associated with intravenous methadone.
@nl
prefLabel
QTc interval prolongation associated with intravenous methadone.
@ast
QTc interval prolongation associated with intravenous methadone.
@en
QTc interval prolongation associated with intravenous methadone.
@nl
P2093
P1433
P1476
QTc interval prolongation associated with intravenous methadone
@en
P2093
Alexander N Katchman
Craig A Kornick
Deborah L Keefe
Glenn Schulman
Howard T Thaler
John C Pezzullo
Juan Santiago-Palma
Michael J Kilborn
Paolo L Manfredi
Richard Payne
P304
P356
10.1016/S0304-3959(03)00205-7
P407
P577
2003-10-01T00:00:00Z